Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-09-08 | Amended | $74,870,150 | Unknown | Equity and Debt | SEC link | |
| 2023-04-14 | New | $26,619,532 | $26,619,532 | Equity and Debt | 06b | SEC link |
| 2020-05-22 | Amended | $9,356,749 | $7,000,000 | Equity Only | 06b | SEC link |
| 2019-05-17 | New | $2,356,749 | $2,356,749 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Aikaterini Akasoglou | Director |
| Houman Ashrafian | Director |
| Laurence Barker | Director |
| Daniel D Burgess | Director |
| Laia Crespo Martin | Director |
| Olga Danilchanka | Director |
| David Dolby | Director |
| Tara Nickerson | Director, Executive |
| Michael Quigley | Director, Executive |
| Michael Ross | Director |
| Tracy Saxton | Director |
| Leslie Schulze | Executive |
| Edward Spack | Executive |
| Jeffrey Stavenhagen | Executive |
| Jeffrey Stavenhagen, Ph.D. | Executive |